We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSFG
2051
DELISTED
First Savings Financial Group
FSFG
$24K ﹤0.01%
1,194
+543
+83% +$10.3K
GEF.B icon
2052
Greif Class B
GEF.B
$4.21B
$24K ﹤0.01%
544
+393
+260% +$18K
IESC icon
2053
IES Holdings
IESC
$15.2B
$24K ﹤0.01%
1,234
+951
+336% +$17.2K
LEN.B icon
2054
Lennar Class B
LEN.B
$20.8B
$24K ﹤0.01%
659
-13,981
-95% -$547K
NFE icon
2055
New Fortress Energy
NFE
$101M
$24K ﹤0.01%
2,049
+1,212
+145% +$14K
NGD
2056
DELISTED
New Gold Inc
NGD
$24K ﹤0.01%
25,227
+14,482
+135% +$11.5K
NGL icon
2057
NGL Energy Partners
NGL
$2.11B
$24K ﹤0.01%
+1,593
New +$22.8K
PAR icon
2058
PAR Technology
PAR
$735M
$24K ﹤0.01%
857
+850
+12,143% +$21.9K
PNR icon
2059
Pentair
PNR
$11B
$24K ﹤0.01%
640
-5,930
-90% -$225K
PRK icon
2060
Park National Corp
PRK
$3.67B
$24K ﹤0.01%
240
+205
+586% +$19.9K
RDNT icon
2061
RadNet
RDNT
$5.69B
$24K ﹤0.01%
+1,718
New +$22K
SBSW icon
2062
Sibanye-Stillwater
SBSW
$7.53B
$24K ﹤0.01%
5,130
-6,295
-55% -$24.9K
ITCI
2063
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$24K ﹤0.01%
1,885
-2,340
-55% -$30K
VRTV
2064
DELISTED
VERITIV CORPORATION
VRTV
$24K ﹤0.01%
+1,238
New +$28.5K
SPPI
2065
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$24K ﹤0.01%
2,765
+2,565
+1,283% +$22.9K
CSII
2066
DELISTED
Cardiovascular Systems, Inc.
CSII
$24K ﹤0.01%
550
+513
+1,386% +$19.9K
SHSP
2067
DELISTED
SharpSpring, Inc.
SHSP
$24K ﹤0.01%
+1,807
New +$30.2K
QEP
2068
DELISTED
QEP RESOURCES, INC.
QEP
$24K ﹤0.01%
3,274
+1,230
+60% +$8.97K
CYOU
2069
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$24K ﹤0.01%
2,544
+1,817
+250% +$28K
ACHN
2070
DELISTED
Achillion Pharmaceuticals
ACHN
$24K ﹤0.01%
+8,837
New +$26.1K
PVTL
2071
DELISTED
Pivotal Software, Inc.
PVTL
$24K ﹤0.01%
+2,250
New +$39.9K
UGAZ
2072
DELISTED
VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2
UGAZ
$24K ﹤0.01%
+146
New +$33.4K
QIWI
2073
DELISTED
QIWI PLC
QIWI
$24K ﹤0.01%
1,242
+1,064
+598% +$17.1K
ACB
2074
Aurora Cannabis
ACB
$185M
$23K ﹤0.01%
24
-82
-77% -$82.4K
ASA
2075
ASA Gold and Precious Metals
ASA
$1.09B
$23K ﹤0.01%
+1,980
New +$19.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.